The short version
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Brevibloc
Esmolol Hydrochloride · ESMOLOL HYDROCHLORIDE 10 mg/mL · Injection · Intravenous · Baxter Healthcare Company
NDC 10019-0115-01 · 25 VIAL in 1 CARTON / 10 mL in 1 VIAL · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$21.33
Reported to Texas DSHS · 2026 annual filing · Baxter Healthcare Corporation
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 10 MG
$0.230
HCPCS J1805 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2025)
$169
61 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Baxter Healthcare CorporationUnited Statesanalysis · label · manufacture · pack · sterilize
- analysis
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA019386
- TE code
- AP
- Approval date
- Aug 15, 1988
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class II · TerminatedApr 12, 2016Baxter Healthcare Corp. — Discoloration: presence of atypical yellow discoloration of the solution .
- Class II · TerminatedJun 16, 2014Baxter Healthcare Corp. — Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.
Manufacturers of Esmolol Hydrochloride (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Baxter Healthcare Company | ESMOLOL HYDROCHLORIDE 20 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Baxter Healthcare Corporation | ESMOLOL HYDROCHLORIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | ESMOLOL HYDROCHLORIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Henry Schein, Inc | ESMOLOL HYDROCHLORIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| HF Acquisition Co LLC, DBA HealthFirst | ESMOLOL HYDROCHLORIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Medical Purchasing Solutions, LLC | ESMOLOL HYDROCHLORIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | ESMOLOL HYDROCHLORIDE 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | ESMOLOL HYDROCHLORIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Baxter Healthcare Company | ESMOLOL HYDROCHLORIDE 10 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Brevibloc — NDC 10019-0115-01," retrieved September 3, 2026, https://drugdashboards.com/drug/10019011501.
Free to cite with attribution — see how the data is put together.